Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
NCT05115019
A Clinical Trial to Evaluate the Efficacy of RUTI® to Reduce the Severity of SARS-CoV-2 Infection (COVID-19)
Phase: Phase 2/3
Role: Lead Sponsor
Start: Dec 31, 2021
Completion: Apr 30, 2022